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Objectives: This study was undertaken to test the hypothesis that the myocardial
protective effect of moderate hypothermia during cardiopulmonary bypass involves
upward regulation of heat shock protein 72.
Methods: Sixteen young pigs were randomly assigned to a temperature regimen
during standardized cardiopulmonary bypass of normothermia or moderate
hypothermia (temperatures 37°C and 28°C, respectively, n  8 per group).
Myocardial probes were sequentially sampled from the right ventricle before
and during bypass and 6 hours after bypass. Messenger RNA encoding for heat
shock protein 72 was assessed by competitive reverse transcriptase–polymerase
chain reaction, and heat shock protein 72 synthesis was assessed by Western blot
and immunohistochemical methods. Induction of apoptosis was assessed by
gene expression of apoptosis-regulating proteins (Bcl-xL, Bak, and Fas) accord-
ing to competitive reverse transcriptase polymerase chain reaction. Apoptotic
cells were identified with an in situ apoptosis-detection kit (terminal deoxynu-
cleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling) in
combination with morphologic criteria. Necrotic cells were detected by standard
histologic methods.
Results: Moderate hypothermia rather than normothermia was associated with
earlier and higher gene expression and synthesis of heat shock protein 72 in the
myocardium during and after cardiac surgery. In the hypothermia group both heat
shock protein 72 and the messenger RNA encoding it were detected as soon as 30
minutes after initiation of bypass and before aortic clamping, whereas in the
normothermia group they were not detected before aortic clamping. Immunohisto-
chemical methods showed localization of heat shock protein 72 in the cardiomyo-
cytes, endothelial cells, and macrophages. Although the percentage of necrotic cells
in the myocardium was lower in the hypothermic group, the induction of apoptosis
regulatory proteins and the percentage of apoptotic cells did not differ between the
groups.
Conclusions: These results suggest that the myocardial protective effect of
moderate hypothermia during cardiopulmonary bypass involves upward
regulation of heat shock protein 72 and inhibition of necrosis but not of
apoptosis.
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In a recent experimental study, we showed thatmoderate hypothermia during cardiopulmonary by-pass (CPB) attenuates the systemic inflammatoryreaction associated with cardiac surgery and pro-vides organ protection by inducing an anti-inflam-matory cytokine balance.1 In this respect, the myo-
cardium of an animal subjected to moderately hypothermic
CPB shows less histologic and ultrastructural signs of cell
damage and cell death than does that of a control animal
operated on under normothermia.2 The mechanisms control-
ling cell damage and cell death are complex. They involve
natural protective processes that repress the production of
proinflammatory and harmful proteins and control cell death
by inhibiting the necrosis or the apoptosis pathways.3 Both
apoptotic and necrotic forms of cell death are induced by
death domain receptors. Whereas necrosis is strongly in-
flammatory and devastating to neighboring tissues, how-
ever, apoptosis is a noninflammatory, self-regulating pro-
cess that could limit tissue damage and contribute to the
removal of activated inflammatory cells.4,5 Apoptosis is
related to the expression of the surface receptor Fas6 and
activation of the caspase pathway,7,8 which is controlled by
the Bcl-2 protein family of both apoptosis-inhibiting (Bcl-
xL) and apoptosis-promoting proteins (Bak).
A well-known mechanism providing cellular protection
is the induction of heat shock proteins (HSPs). HSPs are
molecular chaperones expressed after cellular insult9 that
exert a protective effect by refolding damaged proteins.9
Experimental studies suggest that HSP-70 could participate
in the control of apoptosis by refolding damaged repressors
of the apoptotic pathway.10 Inducers of the heat shock
response include, among others, heat treatment and inflam-
matory mediators.11 HSP-70 is the member of the HSP
family that has been most extensively studied, and HSP-72,
its inducible form, is exclusively expressed during stress.12
A recent in vitro study has suggested that HSP-70 is also
induced by cold,13 but to date the question of whether
hypothermic CPB would induce HSP-72 expression has not
been addressed. This experimental study was designed to
test the hypothesis that the myocardial protective effect of
moderate hypothermia during CPB is related to upward
regulation of HSP-72.
Material and Methods
This study was conducted according to the guidelines of the
German Animal Protection Law ensuring humane care and was
approved by the supervising state agency for animal experiments.
Sixteen female pigs weighing 38  0.5 kg (mean  SEM) were
randomly assigned to a temperature group during CPB (n  8 per
group): normothermia, with a temperature of 37°C, and moderate
hypothermia, with a temperature of 28°C.
General anesthesia was uniform and consisted of a combination
of ketamine and pentobarbital given in repeated doses as neces-
sary. After endotracheal intubation, the lungs of the animals were
mechanically ventilated with an air and oxygen mixture (inspired
oxygen fraction 0.5). Core temperature was monitored with an
esophageal temperature probe (probe 16561; Datex-Ohmeda Di-
vision, Instrumentarium Corp, Helsinki, Finland). Cefotiam (50
mg/kg) was given intravenously for antibiotic prophylaxis. Cath-
eters were placed in the carotid artery and jugular vein as well as
in the left atrium.
CPB equipment was uniform and consisted of a roller pump
inducing a nonpulsatile flow, a disposable pediatric hollow-fiber
oxygenator, a hard-shell cardiotomy reservoir, an arterial blood
filter, and a bubble trap. The extracorporeal perfusion circuit was
primed with a crystalloid solution. Bovine lung heparin (400
IU/kg) was given for systemic anticoagulation. Both caval veins,
the aorta, and the left atrium were cannulated, allowing the insti-
tution of total CPB. Total duration of CPB was set at 120 minutes
for all animals; this included 30 minutes of perfusion during which
animals operated on in moderate hypothermia were cooled down
to 28°C with a heat exchanger, 60 minutes of perfusion during
which the aorta was crossclamped, and 30 minutes of perfusion
during which pigs undergoing hypothermic CPB were rewarmed
to 37°C. In the normothermia group, perfusion was performed at
37°C. CPB was conducted with a flow index of 2.7 L/(min  m2
body surface area) in all animals, with a target mean systemic
arterial pressure of 60 mm Hg. Immediately after aortic cross-
clamping, cardioplegia was achieved by injection of a single dose
of cold (4°C) crystalloid cardioplegic solution (Bretschneider so-
lution, 30 mL/kg) into the aortic root. Additional topical cooling of
the myocardium was performed by application of 500 mL 4°C cold
saline solution. Myocardial temperature during CPB was moni-
tored with a needle temperature probe placed into the ventricular
septum (Temperature Sensing Catheter; Medtronic HemoTec, Inc,
Englewood, Colo). At the end of CPB, anticoagulation was re-
versed by protamine. Mediastinal drains were placed, and the chest
was closed.
Postoperative Care
The lungs of the pigs were mechanically ventilated until the end of
the experiment (6 hours after sternal closure). Postoperative mon-
itoring included continuous registration of heart rate and rhythm,
mean arterial blood pressure, and left atrial pressure (LAP). Esoph-
ageal temperature and urinary output were also recorded. Target
values for mean arterial blood pressure, LAP, and urinary output
during the whole postoperative period were about 60 mm Hg, 5 to
9 mm Hg, and more than 1.5 mL/(kg  h), respectively. Inotropic
support and diuretic treatment consisting of dopamine and furo-
semide, respectively, were adapted accordingly, as was volume
substitution with a Ringer’s lactate solution.
Tissue samples for reverse transcriptase (RT)–polymerase
chain reaction (PCR) and Western blot were taken from the apex
of the right ventricle before institution of CPB, before aortic
crossclamping, and before opening of the aortic clamp. Additional
sample was taken immediately post mortem for RT-PCR, Western
blot, histologic study, and immunohistochemical study. Samples
for RT-PCR and Western blot were rapidly excised, snap-frozen in
liquid nitrogen, and then stored at 70°C until processing. For
standard histologic and immunohistochemical studies, tissue spec-
imens were fixed in 10% buffered formalin, embedded in paraffin,
and cut in 4- to 6-m thick serial sections.
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Counting of Necrotic and Apoptotic Cells
Four serial sections from the myocardial probe were stained with
hematoxylin and eosin. Morphologic criteria used to determine cell
necrosis were cell swelling, disruption of cell membrane and cell
architecture, lysis of the cell organelles and the nuclei, and hy-
pereosinophilia.14 A cell was considered necrotic if at least one of
these criteria was met. Necrotic cells were counted in 5 different
fields of each slide by light microscopy at 400 magnification by
two different investigators (M.Q., B.K.) blinded to the temperature
group. Their counts differed by less than 10%. An average of 1000
cells were counted per slide; results are reported as the average of
the percentages of necrotic cells counted by each investigator.
Detection of apoptotic cells was performed on replicates of the
paraffin sections with terminal deoxynucleotidyl transferase–
mediated deoxyuridine triphosphate nick-end labeling assay
(ApopTag; Serologicals Corporation, Norcross, Ga) according to
the manufacturer recommendations. For quantification of apopto-
sis, samples with labeled fluorescence staining were investigated
with confocal laser scanning microscopy (Laser Scan Microscopy
LSM 410 invert with Axiovert 135M; Carl Zeiss, Oberkochen,
Germany). Apoptotic cells in 12 different fields were counted (an
average of 1000 cells were counted per slide). Data were reported
as the percentage of apoptotic cells, as averaged from the counts of
both investigators.2 Adjacent hematoxylin and eosin–stained sec-
tions were examined to assess typical morphologic findings of
apoptosis (cell shrinkage, chromatin condensation and margin-
ation, and apoptotic bodies.14
Heat Shock Protein 72 Assay
HSP-72 immunohistochemical assay was performed on paraffin-
embedded tissue sections with the IHC mouse kit (InnoGenex, Inc,
San Ramon, Calif). Briefly, sections were pretreated with a solu-
tion of Peroxide Block to inhibit endogenous peroxidase activity
and incubated with Power Block Reagent to block nonspecific
protein binding. Subsequently, they were incubated with the
monoclonal mouse anti–human HSP-72 antibody (1:200; Stress-
Gen Biotechnologies Corp, Victoria, British Columbia, Canada)
for 2 hours at room temperature. After rinsing with phosphate-
buffered saline solution plus 0.1% polysorbate, the slides were
incubated for 30 minutes with the secondary antibody. The slides
were rinsed with phosphate-buffered saline solution and incubated
for 20 minutes in streptavidin–horseradish peroxidase conjugate.
The color reaction was developed in aminoethyl carbazole sub-
strate. Specimens were counterstained with Mayer hematoxylin.
Appropriate positive and negative controls were used for primary
antibody. Cellular localization of HSP-72 was analyzed with the
Quantimet 600 image analyzer system (Leica Microsystems Nus-
sloch GmbH, Nussloch, Germany).
Reverse Transcriptase–Polymerase Chain Reaction
Total RNA was extracted with the RNeasy Mini Kit (QIAGEN
GmbH, Hilden, Germany). RNA (3 g) was reverse transcribed to
complementary DNA with random hexamers. With pig-specific
primers for HSP-72, Bcl-xL, Bak, Fas and -actin (Table 1),
complementary DNA products were coamplified by PCR. Thirty-
five cycles for Bcl-xL, Bak, and Fas and 38 cycles for HSP-72
were performed after an initial denaturation at 95°C for 2 minutes:
30 seconds at 94°C, 30 seconds at 58°C (60°C for HSP-72), and 30
seconds at 72°C. PCR products were subjected to electrophoresis
in 1.8% agarose gel, stained with ethidium bromide, and photo-
graphed. The predicted lengths of amplification products for the
genes encoding HSP-72, Bcl-xL, Fas, Bak, and -actin were 324,
289, 523, 372, and 233 base pairs, respectively. Results are pre-
sented as the ratio of the band intensities of the RT-PCR product
to the corresponding messenger RNA (mRNA) encoding -actin
(Bio-Rad Multi-Analyst, Bio-Rad Laboratories Inc, Hercules,
Calif).
Western Blot
Myocardial samples were homogenized in lysis buffer (1-mol/L
tris[hydroxymethyl]aminomethane hydrochloride, pH 7.4, 0.5-
mol/L ethylenediaminetetraacetic acid, 10% deoxycholat, and 10%
nonidet P-40) containing the following protease and phosophatase
inhibitors: pepstatin A (2 g/mL), leupeptin (5 g/mL), aprotinin
(5 g/mL), and phenylmethylsulfonyl fluoride (1 mmol/L). Sam-
ples were incubated for 30 minutes at 4°C and centrifuged at
14,000g for 10 minutes at 4°C. Protein quantities were determined
with a modified Bradford assay (Bio-Rad). Sodium dodecyl sul-
fate–polyacrylamide gel electrophoresis was conducted with the
Laemmli buffer system on 12% polyacrylamide gels. Proteins (50
g for each lane) separated on gels were transferred to a polyvi-
TABLE 1. Primers used for polymerase chain reaction amplification
Product Orientation
Gene bank
accession No. 5-3 Sequence
HSP-72 Sense X68213 CCTTCACCGACACCGAGC
Antisense TTGAAGTAGGCAGGCACGGT
Bcl-xL Sense AJ001203 GGTGGTTGACTTTCTCTCCTAC
Antisense CAAAAGTGTCCCAGCCGCC
Bak Sense AJ001204 TTTACCGCCATGAGCAGG
Antisense TAGCCGAAGCCCAGAAGAG
Fas Sense AJ001202 CTGTCAGCCATGCCCTC
Antisense GCCCATAACCAGTGTAGG
-actin Sense U07786 GGACTTCGAGCAGGAGATGG
Antisense GCACCGTGTTGGCGTAGAGG
Cardiopulmonary Support and Physiology Ma et al
726 The Journal of Thoracic and Cardiovascular Surgery ● October 2002
CSP
nylidene difluoride membrane (Millipore GmbH, Eschborn, Ger-
many) with a semidry electroblotting apparatus. Binding of the
primary and secondary antibodies was performed in phosphate-
buffered saline solution (pH 7.5) containing 0.1% polysorbate 20
overnight at 4°C (primary antibodies) and for 1 hour at room
temperature (secondary antibody). Primary antibodies used in im-
munoblotting were mouse anti–human HSP-72 antibody (1:1000
dilution, monoclonal; Stressgen Biotechnologies) and mouse anti–
human –actin antibody (1:2000 dilution, monoclonal; Sigma, St
Louis, Mo). Polyclonal antimouse horseradish peroxidase–conju-
gated secondary antibodies (1:2000 dilution; DAKO Diagnostika
GmbH, Hamburg Germany) were used to reveal the immunoreac-
tive bands with the ECL chemiluminescence system according to
the manufacturer instructions (Amersham Biosciences Europe
GmbH, Freiburg, Germany). Signals for HSP-72 and –actin
produced bands of 70.5 kd and 43 kd, respectively. All protein
signals for HSP-72 were normalized for –actin signals that were
developed on the same blot (NIH imaging 1.61b8. software; Bio-
Rad).
Statistical Analysis
Results are expressed as mean  SEM. Data were analyzed by
analysis of variance with adjustment of P values by the Scheffe´
procedure for repeated comparisons. The t test was used for the
pairwise comparison of mean values. Correlation analysis was
performed with the Pearson correlation coefficient. Data were
analyzed with SPSS statistical software package (SPSS Software
GmbH, Mu¨nchen, Germany).
Results
Esophageal and Myocardial Temperatures
Table 2 summarizes esophageal and myocardial tempera-
tures during and after CPB. Esophageal temperatures during
and after CPB were lower in pigs operated on under mod-
erate hypothermia than in the other group. In contrast,
intergroup differences in myocardial temperature during
and after CPB were not observed or could have been due to
chance, with the exception of that measured before cross-
clamping of the aorta.
Hemodynamics
LAPs measured 1 and 4 hours after CPB tended to be lower
in the hypothermia group than in the normothermia group
(LAP 7.1  0.7 mm Hg vs 9.3  0.8 mm Hg and 7.3  0.6
mm Hg vs 9.5 0.9 mm Hg, respectively, P .050). Heart
rate, mean arterial pressure, and diuresis did not differ
between the groups (data not shown).
Synthesis of Heat Shock Protein 72
HSP-72 expression was not detected in the myocardium at
either the mRNA or the protein level before institution of
CPB but was detected in all animals 6 hours after CPB. At
that time, both HSP-72 gene expression and HSP-72 con-
centration were higher in pigs operated on under moderate
hypothermia than in those operated on under normothermia
(Figures 1 and 2). In the former group, HSP-72 expression
was detected at both mRNA and protein levels as soon as 30
minutes after institution of CPB, before crossclamping of
the aorta, and increased further during myocardial ischemia
but no more after the operation. In contrast, in the normo-
thermia group HSP-72 expression was not detected at either
the mRNA or the protein level before CPB but was only
detected at the end of the period of myocardial ischemia (90
minutes after institution of CPB) and did not increase fur-
ther after the operation (Figures 1, A, and 2, A). Intramyo-
cardial gene expression and concentrations of HSP-72 dur-
ing and after CPB were higher in animals operated on under
moderate hypothermia than in those operated on under
normothermia (Figures 1, B, and 2, B). Expression of
mRNA encoding -actin was not affected by CPB.
Heat Shock Protein 72 Immunohistochemical
Detection
In all animals, HSP-72 was present in the myocardium
sampled 6 hours after CPB and was localized in cardiomy-
ocytes, macrophages, and endothelial cells (Figure 3).
TABLE 2. Esophageal and myocardial temperatures before, during, and after CPB in pigs operated on under moderate
hypothermia or normothermia
Time point
Esophageal temperature Myocardial temperature
28°C 37°C P value 28°C 37°C P value
Before CPB 36.0 0.3 36.1 0.2 .2 35.3 0.1 35.4 0.2 .2
Before aortic crossclamping 28.2 0.3 35.9 0.7 .005 28.1 0.3 34.6 0.4 .001
Immediately after cardioplegia 27.9 0.05 37.1 0.3 .002 12.7 0.6 13.9 1.7 .2
10 min after aortic crossclamping 27.9 0.05 37.3 0.4 .002 18.0 1.7 18.8 1.7 .2
30 min after aortic crossclamping 27.9 0.05 37.5 0.5 .002 23.9 1.1 27.7 2.2 .081
60 min after aortic crossclamping 28.4 1.4 35.8 1.1 .012 28.4 1.4 30.3 1.5 .2
Declamping of aorta 27.9 0.05 37.4 0.3 .002 29.2 1.9 33.0 1.5 .141
End of CPB 35.6 0.3 36.9 0.2 .029 34.9 0.3 35.4 0.8 .2
6 h after CPB 35.9 0.4 37.1 0.6 .019 36.3 0.8 38.2 0.8 .2
Ma et al Cardiopulmonary Support and Physiology
The Journal of Thoracic and Cardiovascular Surgery ● Volume 124, Number 4 727
CS
P
Necrosis
The percentage of necrotic cells in the myocardium was
lower in pigs operated on under hypothermia (0.23% 
0.13%) than in those operated on under normothermia
(2.57%  0.57%, P  .002).
Apoptosis
In all animals, mRNA encoding Fas, Bak, and Bcl-xL was
not detectable in the heart before institution of CPB but was
detectable 6 hours after CPB, without any intergroup dif-
ferences (Table 3). At that time apoptotic bodies and apo-
ptotic cells were also present in the myocardium of animals
of both groups and averaged 0.82%  0.47% in the animals
operated on under hypothermia and 0.33%  0.24% in
those operated on under normothermia (P  .2).
Discussion
In this study, moderate hypothermia during CPB was asso-
ciated with intramyocardial upward regulation of HSP-72
expression and with reduction of myocardial cell necrosis.
This effect of moderate hypothermia on HSP-72 production
is shown here for the first time in the setting of cardiac
surgery but is supported by previous experimental studies.
Indeed, in addition to such commonly accepted activators of
the transcription factor heat shock factor 1 as heat, hypoxia,
reactive oxygen species, and proinflammatory cytokines,9 a
few studies have reported that exposure to cold also induces
gene expression of HSP-70.15,16 In an isolated rat heart
model, hypothermic perfusion (31°C) preceding ischemia
led to expression of mRNA encoding HSP-70.13 In vivo,
however, recovery from hypothermia seems to be necessary
for maximal stimulation of HSP-70 expression in response
to heat shock factor 1.16
A main finding of this study was the presence of HSP-72
in the myocardium as early as 30 minutes after institution of
hypothermic CPB, before institution of cold cardioplegic
arrest. In contrast to that finding, HSP-72 was detectable
only at the end of the period of myocardial ischemia in
animals operated on under normothermia. This observation
suggests that different kinds of stress induced HSP-72 dur-
ing the course of cardiac surgery in both animal groups of
this series. Indeed, 30 minutes after the beginning of CPB,
both esophageal and myocardial temperature were (as ex-
pected) lower in the hypothermia than in the normothermia
group. At that time, proinflammatory cytokine production is
blunted in animals undergoing moderate hypothermic CPB
but not in those operated on under normothermia, as we
have recently shown.1 This indicates the preponderant role
of hypothermia in inducing HSP-72 during the early phase
of hypothermic CPB. In contrast, proinflammatory media-
tors such as tumor necrosis factor (TNF) , either released
Figure 1. A, Expression of mRNA encoding HSP-72 in myocardium before CPB (1), before aortic crossclamping (2),
before removal of aortic clamp (3), and 6 hours after CPB (4) in pigs operated on under moderate hypothermia
(temperature 28°C, circles) and under normothermia (temperature 37°C, squares). Results are shown as ratio of
mRNA encoding HSP-72 to that encoding -actin detected by RT-PCR. Data points represent mean value; error bars
represent SEM. Double asterisk indicates difference versus prebypass value in hypothermia group (P  .042).
Asterisk indicates P < .001 between groups; dagger indicates P .002; double dagger indicates P .007. B, Effect
of core temperature on myocardial expression of mRNA encoding HSP-72 detected by RT-PCR. Results are
representative for 8 independent experiments in each group (moderate hypothermia 28°C, normothermia 37°C). M,
Molecular weight markers; bp, base pairs.
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into the circulation or produced in the myocardium during
myocardial ischemia,1,2 could be responsible for the later
induction of HSP-72 in the normothermia group.17
Another main finding of this study was the significant
reduction of cell death by necrosis but not by apoptosis
related to moderately hypothermic CPB. HSP-70 is well
known to play a key regulatory role in cell survival,18
protecting against cell necrosis.19 Our results showing that
HSP-72–positive staining was present not only in parenchy-
matous cells but also in resident macrophages in the myo-
cardium could indicate its inhibitory role on in situ macro-
phage- and TNF-mediated tissue injury.20 Indeed, HSP-70
decreases TNF- and interleukin 1 production by binding
nuclear factor  B, preventing its translocation into the
nucleus and thus reducing inflammatory response.21 In ad-
dition to this, HSP-70 prevents posttranslational release of
TNF-.22 This could also be a mechanism by which mod-
erate hypothermia blunts TNF- production during cardiac
operations, as we have shown previously.1,2
In contrast to their action against necrosis, the role of
HSPs in the induction of apoptosis is controversial. Because
they refold damaged repressors of the apoptotic pathway or
prevent their degradation, HSPs have been implicated in the
control of apoptosis.10 HSP-70 could also control apoptosis
at the level of signal transduction of apoptosis-regulating
proteins.23 On the other hand, experimental studies have
shown that HSPs are also inducers of apoptosis when non-
lethal endotoxin stimulation occurs before a stress that
normally elicits HSP synthesis.24 This points out the impor-
tance of quality and sequence of stresses imposed on the
investigated organism in determining whether and how the
cells will die.
In our series, although synthesis of HSP-72 was signif-
icantly higher in pigs operated on under moderate hypother-
mia than in the other animals, the levels of gene expression
of apoptosis-regulatory proteins and amounts of apoptotic
cells in the myocardium were similar in the two groups.
This clearly indicates that in our model moderate hypother-
mia did not exert its protective effect by inhibiting apoptotic
cell death. It is conceivable that different factors specific for
each group of animals (hypothermic vs normothermic CPB)
exerted apoptosis-inducing effects. Indeed, hypothermia it-
self is an inducer of apoptosis by inducing expression of the
tumor suppressor protein p53, a temperature-sensitive pro-
tein.25 On the other hand, proinflammatory cytokines re-
leased during normothermic CPB2,26 are inducers of apop-
tosis in various cell types.9 TNF- upwardly regulates Fas
expression and stimulates its type 1 receptor, inducing ap-
optotic events.27 In addition, the anti-inflammatory cytokine
interleukin 10, the circulating levels of which are increased
in the early phase of hypothermic CPB as we have recently
shown,1 is an inducer of apoptosis in patients with sepsis
and is thought to contribute to organ protection by enhanc-
ing the elimination of activated leukocytes.28
It has recently been suggested that the presence of
HSP-70 at the protein level is necessary for the inhibition of
Figure 2. A. Synthesis of HSP-72 measured by Western blot in myocardium before CPB (1), before aortic
crossclamping (2), before removal of aortic clamp (3), and 6 hours after CPB (4) in pigs operated on under moderate
hypothermia (temperature 28°C, circles) and under normothermia (temperature 37°C, squares). Band intensities for
HSP-72 were normalized for band intensities of -actin. Data points represent mean value; error bars represent
SEM. Double asterisk indicates difference versus prebypass value in hypothermia group (P  .068). Asterisk
indicates P  .001 between groups; dagger indicates P  .085; double dagger indicates P  .058. B, Effect of core
temperature on myocardial expression of HSP-72 detected by Western blot. Results are representative for 8
independent experiments in each group (moderate hypothermia 28°C, normothermia 37°C). M, Molecular weight
markers.
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apoptosis and that the apoptosis-promoting protein Fas
leads in turn to inhibition of the heat shock factor 1 and
HSP-70 stress response.29 However, there is usually a lack
of linear correlation between the presence of HSPs and their
protective role, indicating that a critical amount of HSP is
necessary to elicit a protective effect.30 Our results confirm
this and show a relationship between overexpression of
HSP-72 and reduction of cell death by necrosis.
In conclusion, in this study moderate hypothermic CPB,
as compared with normothermic CPB, enhanced gene ex-
pression and synthesis of HSP-72 and reduced cell death by
necrosis. Upward regulation of HSP-72 could be a mecha-
nism by which moderate hypothermia during cardiac oper-
ations protects against organ damage.
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